The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma
Open Access
- 14 January 2020
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 11 (2) , 175-187
Abstract
Oncotarget | https://doi.org/10.18632/oncotarget.27431 Klara Fodor, Nikoletta Dobos, Andrew Schally, Zita Steiber, Gabor Olah, Eva Sipos, Lorant Szekvolgyi, Gabor HalmosKeywords
This publication has 56 references indexed in Scilit:
- Current and emerging treatment options for uveal melanomaClinical Ophthalmology, 2013
- Luteinizing hormone‐releasing hormone ( LHRH ) receptor agonists vs antagonists: a matter of the receptors?BJU International, 2013
- Hormonal manipulation of benign prostatic hyperplasiaCurrent Opinion in Urology, 2013
- Combining Growth Hormone-Releasing Hormone Antagonist With Luteinizing Hormone-Releasing Hormone Antagonist Greatly Augments Benign Prostatic Hyperplasia ShrinkageJournal of Urology, 2012
- Therapeutic Options in Metastatic Uveal Melanoma2011
- Does ocular treatment of uveal melanoma influence survival?British Journal of Cancer, 2010
- Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?Dermatology Research and Practice, 2010
- Maspin Suppresses Survival of Lung Cancer Cells through Modulation of Akt PathwayCancer Research and Treatment, 2010
- Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic typesCancer, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976